Every Country, Every Family: Time to Act for Group B Streptococcal Disease Worldwide.

Joy E. Lawn, Jaya Chandna, Proma Paul, Mark Jit, Caroline Trotter, Philipp Lambach, and Ajoke Sobanjo Ter-Meulen Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene and Tropical Medicine, London, United Kingdom; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom; Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom; Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland; and Bill & Melinda Gates Foundation, Seattle, Washington, USA

[1]  Q. Bassat,et al.  Short and long-term outcomes of GBS invasive disease in Mozambican children: Results of a case cohort and retrospective observational study and implications for future vaccine introduction. , 2021, Clinical Infectious Diseases.

[2]  S. Madhi,et al.  South African children: A case cohort study of neurodevelopmental impairment in survivors of invasive Group B Streptococcus disease aged 5- to 8-years. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  E. Horváth-Puhó,et al.  Sex Differences in Long-term Outcomes After Group B Streptococcal Infections During Infancy in Denmark and the Netherlands: National Cohort Studies of Neurodevelopmental Impairments and Mortality , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  C. Pecenka,et al.  A financial and global demand analysis to inform decisions for funding and clinical development of GBS vaccines for pregnant women. , 2021, Clinical Infectious Diseases.

[5]  J. Lawn,et al.  South Indian Children’s Neurodevelopmental Outcomes After Group B Streptococcus Invasive Disease: A Matched-Cohort Study , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  B. Greenwood,et al.  Defeating meningitis by 2030 – an ambitious target , 2021, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[7]  M. Jit,et al.  The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making , 2021, BMC Medicine.

[8]  E. Horváth-Puhó,et al.  Mortality, neurodevelopmental impairments, and economic outcomes after invasive group B streptococcal disease in early infancy in Denmark and the Netherlands: a national matched cohort study , 2021, The Lancet. Child & adolescent health.

[9]  M. Jit,et al.  Systematic Review on the Acute Cost-of-Illness of Sepsis and Meningitis in Neonates and Infants. , 2019, The Pediatric infectious disease journal.

[10]  S. Madhi,et al.  Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  S. Madhi,et al.  Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  S. Madhi,et al.  Stillbirth With Group B Streptococcus Disease Worldwide: Systematic Review and Meta-analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  S. Madhi,et al.  Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  S. Madhi,et al.  Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  S. Madhi,et al.  Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates? , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  S. Cousens,et al.  4 million neonatal deaths: When? Where? Why? , 2005, The Lancet.